Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today.

Biotechnology

Education

Ambys Medicines

Ambys Medicines' headquarters in South San Francisco, CA, United States

John Choi

Priyadarshini Podishetti

Marianne Rayos

Stanley Hollenbach

Abeba Demelash Ph.D.

Gabriel Peixoto

Juan Carlos Izpisua Belmonte

Holger Willenbring

Martin Burke

Charles Homcy

Chinweike Ukomadu

Yury Popov

Raymond Chung

Scott Naugler

Brendan Lee

Steven D. Colquhoun

Daniel P. Anderson

Nenad Grmusa

David Russell

Paul Kwo

Stephen Strom

Jeff Tong

Robert Fisher

Robert S. Brown Jr.

The Scientific and Clinical Team at Ambys Medicines is responsible for driving the company's research and development efforts in regenerative and restorative liver therapies. This team integrates cutting-edge scientific research with clinical expertise to design, implement, and oversee preclinical and clinical studies. Their work involves ensuring the quality and efficacy of novel treatments, conducting bioanalytical assessments, and advancing the development of innovative therapeutic modalities like cell and gene therapy to restore liver function and prevent liver failure.

Scientific and Clinical Team

The Directors and People Operations team at Ambys Medicines oversees the strategic direction and operational management of the company, including aligning clinical and research goals with business objectives. This team also focuses on enhancing employee engagement, optimizing HR processes, and fostering a supportive work culture to drive the company's mission of developing transformative therapies for advanced liver disease.

Directors and People Operations

The Leadership Team at Ambys Medicines drives the strategic direction and operational efficacy of the company, leveraging expertise in liver disease and regenerative medicine. Comprising key leaders in strategy, regulatory affairs, finance, and human resources, the team collaborates to guide the development of innovative therapies, ensuring alignment with regulatory standards and optimizing resources to address the urgent medical needs of patients with advanced liver disease.

Leadership Team

This department oversees compliance with laws and regulations related to drug development and approval.

Regulatory Affairs

This department focuses on conducting scientific research and developing innovative solutions.

Research and Development

Ambys Medicines

Org chart

Board & advisors

Teams

Scientific and Clinical Team

Directors and People Operations

Leadership Team

Regulatory Affairs

Research and Development

Offices

Ambys Medicines

Org chart

Board & advisors

Teams

Scientific and Clinical Team

Directors and People Operations

Leadership Team

Regulatory Affairs

Research and Development

Offices

Related companies